Lifespan Ventures

Overview

Lifespan Ventures is a venture capital firm dedicated to investing in early-stage healthcare companies focused on longevity and aging research. The firm seeks to support innovative companies developing diagnostics, therapeutics, and technologies aimed at extending healthy human lifespan and addressing age-related diseases. Lifespan Ventures is committed to advancing the field of longevity by providing capital and strategic guidance to promising startups. The firm's investment strategy encompasses a broad range of stages, from pre-Seed to growth stages, including Series A, Series B, and Pre-IPO rounds. Lifespan Ventures primarily focuses on the United States but is open to global opportunities that align with its mission. The firm has a diverse portfolio spanning various industries within the healthcare sector, including biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, health IT, consumer health, regenerative medicine, genomics, proteomics, cell therapy, and immunotherapy. Lifespan Ventures has demonstrated a proactive approach in its investment activities. In October 2023, the firm invested in NaNotics LLC, a preclinical-stage biopharmaceutical company developing NaNots™, novel subtractive nanoparticles designed to treat diseases by capturing and clearing pathogenic molecules from the blood. This investment highlights Lifespan Ventures' commitment to supporting innovative solutions in the longevity biotech space. Additionally, in October 2023, Lifespan Ventures invested in Matter Bio, a longevity holding company focused on preserving genome integrity. Matter Bio's approach involves advancing multiple scientific breakthroughs targeting critical junctures of information loss in the genome, aiming to prevent diseases of aging and increase healthy lifespan. Through these strategic investments, Lifespan Ventures continues to contribute to the advancement of longevity research and the development of therapies that have the potential to transform healthcare and improve quality of life for aging populations.